Related Experiment Videos
Acetoacetate coenzyme A transferase activity in rat hepatomas
Cancer Research
|September 1, 1975
Summary
Succinyl-coenzyme A:acetoacetate CoA transferase (CoA transferase) is low in normal liver but high in neonatal liver and rat hepatomas. Faster-growing tumors show increased CoA transferase activity, indicating ketone body utilization capacity.
Area of Science:
- Biochemistry
- Oncology
- Metabolic research
Background:
- Succinyl-coenzyme A:acetoacetate CoA transferase (CoA transferase) initiates ketone body utilization in non-hepatic tissues.
- Understanding CoA transferase levels is crucial for metabolic studies in various physiological and pathological conditions.
Purpose of the Study:
- To investigate the presence and activity of CoA transferase in different rat liver conditions and transplantable hepatomas.
- To compare the biochemical and kinetic properties of CoA transferase from normal liver, tumor tissue, and skeletal muscle.
Main Methods:
- Assay of CoA transferase activity in normal, regenerating, neonatal, and tumor-bearing rat livers.
- Analysis of CoA transferase in a series of Morris hepatomas with varying growth rates.
- Biochemical characterization including size, kinetic parameters, and isoelectric focusing of CoA transferase from normal and hepatoma tissues.
Main Results:
- CoA transferase levels are very low in normal, host, and regenerating liver but significantly elevated in neonatal liver and hepatomas.
- A positive correlation exists between CoA transferase content and tumor growth rate in Morris hepatomas.
- The enzyme from fast-growing hepatoma (7288Ctc) shares biochemical similarities with that from skeletal muscle, including size, mechanism, kinetic parameters, and isoelectric point.
Conclusions:
- Faster-growing hepatomas possess substantial capacity for ketone body utilization.
- The biochemical properties of CoA transferase are conserved between highly proliferative tumors and differentiated non-hepatic tissues like skeletal muscle.